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Antibiotic drug discovery is an indis-
pensable process to combat aggressive
ability of pathogenic microorganisms
and emerging infectious diseases against
health and well-being of people through-
out the world. According to the updated
and expanded data on natural prod-
ucts presented by Newman and Cragg
(2012), the utility of natural prod-
ucts as sources of novel structures is
still alive and the anti-infective area
depends on natural products and their
structures. The natural products with
pharmaceutical importance are largely
produced from primary and secondary
metabolism of plants and microorgan-
isms. Microbial natural products have
made an incredible contribution to the
antibiotic drug discovery and develop-
ment process over last seven decades
(Demain and Sanchez, 2009). Alexander
Fleming’s discovery of penicillin from
a mold in 1928 and its subsequent
progress into a medicine in the 1940s
laid the foundation for development
of microbial natural products as drugs
(Fleming, 1929; Chain et al., 1940). Later,
Waksman’s report of actinomycin in
1940 and subsequent reports of strep-
tothricin in 1942 and streptomycin in
1943 introduced the actinomycets as
source of antibiotics (Waksman and
Woodruff, 1940;Waksman, 1943; Comroe,
1978). In the end of 20th century, sev-
eral actinobacterial natural products had
found extensive applications in clinical
field as antibacterial, antifungal, antipar-
asitic, and anticancer agents (Butler,
2004). Of all the reported bioactive
compounds of microbial origin, 45%
are produced by actinomycetes (Berdy,
2005). Moreover, 90% of practically used
antibiotics are originated from the acti-
nomycetes (Hamaki et al., 2005) and they
are still being the chief natural antibiotic
producers.
Since the report of streptomycin from
the strains of Streptomyces griseus there
has been a rapid escalation in antibiotic
discovery from the genus Streptomyces
(largest genus of Actinobacteria).
Subsequently, members of this genus have
become renowned as a prime source of
natural antibiotics (Mohamed and Galal,
2005; Jose et al., 2011). It has been evi-
denced by continuing production of string
of commercially important antibiotics like
daptomycin, erythromycin, fosfomycin,
lincomycin, neomycin, streptomycin, and
tetracycline from industrially-important
members of the genus Streptomyces
(Mahajan and Balachandran, 2012).
However, the likelihood of finding novel
antimicrobial leads from these distinc-
tive actinomycetes has recently dwindled
upon the rediscovery of known com-
pounds (Koehn and Carter, 2005) and the
focus of current microbial drug discovery
programs being reoriented toward other
promising microbial resources. Other side
of the coin, emergence of new infectious
diseases and antibiotic resistance provoked
in earlier infectious diseases has raised the
need for novel antibiotics.
Against this backdrop, rare acti-
nomycetes (non-streptomycetes) are
currently isolated from diverse envi-
ronments and intensively studied for
potential leads for antibiotic discovery
programs. The rare actinomycetes are
usually regarded as strains of actino-
mycetes whose isolation frequency by
conventional methods is much lesser
than that of streptomycete strains (Seong
et al., 2001). According to a recent
review by Tiwari and Gupta (2012), this
non-streptomycete actinomycetes group
comprising diverse bioactive secondary
metabolite producing members under
following genera: Actinomadura, Actino-
planes, Amycolatopsis, Dactylosporangium,
Kibdelosporangium, Kitasatospora, Micro-
biospora, Planomonospora, Planobispora,
Salinispora, Streptosporangium, and Verru-
cosispora. The list has further been
extended by recent reports of bioactive
compounds from members of other rare
genera, Nonomuraea (Beltrametti et al.,
2003; Jose and Jebakumar, 2012; Flatt
et al., 2013), Actinoalloteichus (Fu et al.,
2011; Wang et al., 2013), Pseudonocardia
(Oh et al., 2009; Barke et al., 2010; Carr
et al., 2012), Saccharothrix (Murakami
et al., 2009; Aouiche et al., 2012;
Nakae et al., 2013), and Actinosynnema
(Wei et al., 2010; Siyu-Mao et al., 2012).
Moreover, basic knowledge of the habitats,
physiology, and secondary metabo-
lite diversity of the rare actinomycetes
gradually increased (Tiwari and Gupta,
2012). Out of more than eight thousand
antimicrobial products described in the
ABL database, 16% produced by strains
belong to rare genera of actinomycetes
(Lazzarini et al., 2001).
Distribution of the rare actinomycetes
has been found to be wide in terrestrial
and aquatic environments (Tiwari and
Gupta, 2012). Fair isolation methods have
become indispensable as these rare acti-
nomycetes exert slow growth while fast
growing streptomycetes and fungal strains
dominate in normal actinomycetes iso-
lation methods. Different and isolation
methods have to be employed for acquir-
ing diverse actinomycetes from different
sources. These methods employ variety of
pretreatment techniques and enrichment
techniques along with specific isolation
medium amended with specific antimi-
crobial agents (Hayakawa, 2008). Tiwari
and Gupta (2013) have reviewed almost
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all the selective isolation methods that
have been developed to date for isola-
tion of rare actinomycetes. In fact, all
the isolation methods are designed to
favor the growth of rare actinomycetes
while suppressing the growth of undesired
microorganisms.
In recent times, much attention has
been given to isolate rare actinomycetes
from diverse previously unexplored
common as well as uncommon extreme
environments. Numerous rare actino-
mycetes have been isolated from variety
of soil samples (Seong et al., 2001; Gu
et al., 2007; Li et al., 2007, 2010; Ara
et al., 2013), plant materials (Qin et al.,
2009; Janso and Carter, 2010; Zhao et al.,
2011), marine sources (Zhang et al., 2006;
Sun et al., 2010; Radhakrishnan et al.,
2011; Goodfellow et al., 2012), extreme
saline zones (Jose and Jebakumar, 2013),
Volcanic zones (Lee and Lee, 2011) hyper
arids (Okoro et al., 2009), glaciers (Reddy
et al., 2010; Zhang et al., 2012), and much
more. As a result, an array of rare actino-
mycetes available for current antimicrobial
drug screening programs has increased. A
comprehensive recent review by Tiwari
and Gupta (2013) summarizes the reports
of isolation rare actinomycetes from differ-
ent natural habitats throughout the world.
It is disclosed that, an unexpected variety
of rare actinomycetes populates in diverse,
previously unexplored natural habitates.
In conclusion, rare actinomycetes
are being unveiled as highly prospective
sources of bioactive compounds. Paths
have already been sketched to reach these
rare microorganisms but strides should be
taken with specific isolation strategies. The
progressing discoveries of novel bioactive
compounds from these rare actinomycetes
(non-streptomycetes) apparently opine
that these organisms nourish the current
antibiotic drug discovery programs.
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